SCHEMBL3854701

SCHEMBL3854701

Fc1ccc(-c2nn(C(c3ccccc3)(c3ccccc3)C3C=CC=CC3)cc2-c2ccc3ncc(-c4noc(C5CC5)n4)n3c2)c(F)c1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 3/20 0.37
MAPK14 Q16539 3/20 0.35
CNR2 P34972 5/20 0.33
CNR1 P21554 2/20 0.33
KIT P10721 4/20 0.32
PIK3CB P42338 1/20 0.32
MTOR P42345 1/20 0.32
CDK19 Q9BWU1 1/20 0.32
LMNA P02545 2/20 0.31
MEN1 O00255 1/20 0.31
MAPT P10636 1/20 0.31
HTT P42858 1/20 0.31
RECQL P46063 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
ALOX15 P16050 1/20 0.30
TSHR P16473 1/20 0.30
MAPK1 P28482 1/20 0.30
TGFBR1 P36897 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3847654 0.94 PIK3CA (0.34) PIK3CAKITPIK3CBMTORCDK19
SCHEMBL3846802 0.94 CNR2 (0.34) PIK3CAMAPK14CNR2CNR1KIT
SCHEMBL3847076 0.93 LMNA (0.33) PIK3CACNR2KITPIK3CBMTOR
SCHEMBL3846559 0.93 CNR2 (0.34) PIK3CACNR2KITPIK3CBMTOR
SCHEMBL3845899 0.92 TP53 (0.33) PIK3CAKITPIK3CBMTORCDK19
SCHEMBL3845668 0.91 KIT (0.32) PIK3CACNR2KITPIK3CBMTOR
SCHEMBL3846504 0.90 PIK3CA (0.38) PIK3CAMAPK14PIK3CBMTORCDK19
SCHEMBL3849108 0.90 PIK3CA (0.36) PIK3CAMAPK14PIK3CBMTORCDK19
SCHEMBL3852721 0.90 HRH3 (0.32) KIT
SCHEMBL3846858 0.90 CNR1 (0.32) PIK3CACNR2CNR1PIK3CBMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed